• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[利福平与乙胺丁醇严格监督下间歇治疗慢性肺结核患者的即时疗效]

[Immediate results of strictly supervised, intermittent treatment with rifampicin and ethambutol in patients with chronic pulmonary tuberculosis].

作者信息

Josefovics F, Vojth B, Vojth V

出版信息

Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1977 Jan-Mar;26(1):35-8.

PMID:191889
Abstract

Of the 118 patients suffering from chronic pulmonary tuberculosis, living within the district of the Tîrgu Mureş Tuberculosis Dispensary, 100 accepted a strictly surveyed treatment and of these 90 continued for at least 6 months. The present paper reports on the immediate radiologic and bacteriological results and the factors influencing them. The following conclusions were drawn: 1) A 2/7 Rifampicin/Etambutol strictly supervised treatment is the most efficient method for neutralizing chronic bacillary sources. 2) The age and origin of the patients, the duration and extent of the pulmonary process, duration of the treatment and associated diseases are the factors that furnish the prognosis of the expected results. 3) Apart from the very good results obtained the method cannot solve all chronic cases and the classical antiepidemic measures must be applied in continuation.

摘要

在特尔古穆列什结核病防治所辖区内生活的118例慢性肺结核患者中,100例接受了严格监测的治疗,其中90例持续治疗至少6个月。本文报告了近期的放射学和细菌学结果以及影响这些结果的因素。得出以下结论:1)严格监督下的2/7利福平/乙胺丁醇治疗是消除慢性细菌源的最有效方法。2)患者的年龄和籍贯、肺部病变的持续时间和范围、治疗持续时间以及相关疾病是决定预期结果预后的因素。3)除了取得的非常好的结果外,该方法不能解决所有慢性病例,必须继续采用经典的防疫措施。

相似文献

1
[Immediate results of strictly supervised, intermittent treatment with rifampicin and ethambutol in patients with chronic pulmonary tuberculosis].[利福平与乙胺丁醇严格监督下间歇治疗慢性肺结核患者的即时疗效]
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1977 Jan-Mar;26(1):35-8.
2
[Organization, administration and results of strictly supervised treatment with rifampicin and ethambutol in a group of chronic tubercular patients in the Constanta area].[康斯坦察地区一组慢性结核病患者采用利福平和乙胺丁醇严格监督治疗的组织、管理及结果]
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1974 Oct-Dec;23(5):445-50.
3
[Results of the use of rifampicin and ethambutol in complex treatment of chronic destructive pulmonary tuberculosis].[利福平与乙胺丁醇在慢性破坏性肺结核综合治疗中的应用结果]
Probl Tuberk. 1976;3:27-31.
4
[Results of intermittent biweekly treatment with rifampicin and ethambutol in silicotuberculosis].
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1979 Jan-Mar;28(1):39-46.
5
[Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation].利福平联合乙胺丁醇及其他抗结核药物治疗肺结核患者。早期结果。I. 细菌学评估
Pneumonol Pol. 1976;44(1):55-60.
6
[Comparative daily followed clinical study of treatment of chronic pulmonary tuberculosis with various combinations of ethambutol and rifampicin. Daily and intermittent method].[乙胺丁醇与利福平不同组合治疗慢性肺结核的每日随访对比临床研究。每日及间歇疗法]
Gruzlica. 1975 Dec;43(12):1067-98.
7
[Intermittent treatment of "intractable chronic tuberculosis" by combined rifampicin-ethambutol: preliminary results of a controlled survey made in Algeria].利福平联合乙胺丁醇对“顽固性慢性结核病”的间歇性治疗:阿尔及利亚一项对照研究的初步结果
Rev Tuberc Pneumol (Paris). 1970 Jun;34(4):559-66.
8
[Results of treatment of chronic tuberculosis with rifampicin and ethambutol at the sanatoria run by the Railroad Health Services].[铁路卫生服务机构所属疗养院采用利福平与乙胺丁醇治疗慢性肺结核的结果]
Gruzlica. 1974 May;42(5):393-5.
9
[Long-term results of treatment with rifampicin and ethambutol in hyperchronic pulmonary tuberculosis with polyresistant bacilli].[利福平与乙胺丁醇治疗多耐药杆菌超慢性肺结核的长期结果]
Ftiziologia. 1973 Sep-Oct;22(5):477-84.
10
[Treatment of new and chronic tuberculous patients with ethambutol and Rifampicin (author's transl)].用乙胺丁醇和利福平治疗新患和慢性结核病患者(作者译)
Z Erkr Atmungsorgane. 1976 May;145(2):220-6.